| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/19/1997 | EP0758234A1 Method and composition for treating renal disease and failure |
| 02/19/1997 | EP0654026B1 Isoserine derivatives and their use as leukotriene antagonists |
| 02/19/1997 | EP0614362B1 Pharmaceutical compositions based on ebastine or analogues thereof |
| 02/19/1997 | CN1143323A Bicyclic fibrinogen antagonists |
| 02/19/1997 | CN1143319A Compound and methods for treatment of cardiovascular, inflammatory and immune disorders |
| 02/19/1997 | CN1143076A 4-fluoroalkyl substituted phenacyl guanidine, its preparing method, application as medicine or diagnosis agent and medicine containing such compound |
| 02/19/1997 | CN1142945A Medcine for curing cerebrovascular disturbance with psychonosema |
| 02/19/1997 | CN1034077C Preparation of new pyrido|2,3-f¨|1,4¨ thiazepines |
| 02/19/1997 | CN1034075C Benzothiazepine derivatives |
| 02/19/1997 | CN1034073C Process for substituted pyridyl-dihydroxy-heptenoic sodium salt |
| 02/18/1997 | US5604256 Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition |
| 02/18/1997 | US5604251 Hypotensive agents |
| 02/18/1997 | US5604247 Chromone Derivatives |
| 02/18/1997 | US5604236 Beta-carboline thromboxane synthase inhibitors |
| 02/18/1997 | US5604227 Excitatory amino acid antagonist; mono, di or tri-acetylation or alkylation |
| 02/18/1997 | US5604223 Treating epilepsy, nervous system disorder |
| 02/18/1997 | US5604221 Treating congestive heart failure, irritable bowel syndrome |
| 02/18/1997 | US5604216 Diluted mixtures for use as drugs or nutritional supplements |
| 02/18/1997 | US5604207 Sialyl Lex analogues as inhibitors of cellular adhesion |
| 02/18/1997 | US5604115 Liver enriched transcription factor |
| 02/18/1997 | US5604103 Kit for detection of clinical marker in kidney stone disease |
| 02/18/1997 | US5603957 Microcapsules for the controlled release of acetylsalicyclic acid in the gastrointestinal environment |
| 02/18/1997 | US5603943 Physiologically active substance homogeneously dispersed in and adsorbed on polyvalent metal carrier of specified particle size |
| 02/17/1997 | CA2183307A1 Endothelin receptor antagonists |
| 02/15/1997 | CA2183052A1 Use of acyl-substituted aminopyrans |
| 02/15/1997 | CA2183048A1 Substituted 4h-pyrans |
| 02/13/1997 | WO1997005285A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005250A2 Receptor ligand vegf-c |
| 02/13/1997 | WO1997005241A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005139A1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 02/13/1997 | WO1997005134A1 Heterocyclic compounds for treating myocardial ischaemia |
| 02/13/1997 | WO1997005127A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 02/13/1997 | WO1997004806A1 Remedy for neurological disorders |
| 02/13/1997 | WO1997004781A1 Endothelin receptor antagonists |
| 02/13/1997 | WO1997004779A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004774A1 Endothelin receptor antagonists |
| 02/13/1997 | WO1997004773A1 Endothelin receptor antagonists |
| 02/13/1997 | WO1997004772A1 Endothelin receptor antagonists |
| 02/13/1997 | WO1997004769A1 Endothelin receptor antagonists |
| 02/13/1997 | WO1997004768A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | WO1997004767A1 Hydroxyl radical scavenger |
| 02/13/1997 | WO1997004765A1 INHIBITION OF CoA-INDEPENDENT TRANSACYLASE AND APOPTOSIS |
| 02/13/1997 | WO1997004763A1 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 02/13/1997 | WO1997004760A1 Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 02/13/1997 | WO1997004657A1 Novel embolizing compositions |
| 02/13/1997 | DE19529612A1 Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate Sulfonyl or sulfinyl derivatives benzoylguanidine |
| 02/13/1997 | CA2228691A1 Heterocyclic compounds for treating myocardial ischaemia |
| 02/13/1997 | CA2228298A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | CA2228296A1 Endothelin receptor antagonists |
| 02/13/1997 | CA2228293A1 Endothelin receptor antagonists |
| 02/13/1997 | CA2228248A1 Receptor ligand vegf-c |
| 02/13/1997 | CA2228178A1 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 02/13/1997 | CA2227808A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 02/13/1997 | CA2227769A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227694A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2225552A1 Quinolones and their therapeutic use |
| 02/13/1997 | CA2224293A1 Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 02/12/1997 | EP0758021A2 Method for determining the therapeutic activity of metalloproteinase inhibitor compounds, new inhibitor compounds, and the therapeutic use thereof |
| 02/12/1997 | EP0757911A1 New galenic formulations containing fenofibrate and their applications |
| 02/12/1997 | EP0757719A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY |
| 02/12/1997 | EP0757716A1 Dna encoding bradykinin b 1? receptor |
| 02/12/1997 | EP0757670A1 Benzamide derivatives as vasopressin antagonists |
| 02/12/1997 | EP0757669A1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142831A Novel 2-substituted indane-2-mercaploacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 02/12/1997 | CN1142826A Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 02/12/1997 | CN1142819A Morpholine and thiomorpholine tachykinin receptor antagonists |
| 02/12/1997 | CN1142816A Crystalline, polymorphic form of (S,S,S)-n-(1-|2-carboxy-3-(n2-mesyllysylamino)propyl¨-1-cyclopenlylcarbonyl)tyrosine |
| 02/12/1997 | CN1142501A Novel sulphuric acid esters of amino-sugars |
| 02/12/1997 | CN1142370A Capsule for cerebral arteriosclerosis |
| 02/11/1997 | US5602233 Activation and deactivation |
| 02/11/1997 | US5602169 Useful in reducing neuronal damage during ischemic stroke |
| 02/11/1997 | US5602153 Method of using 1-arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds for treatment of a giaucoma disorder |
| 02/11/1997 | US5602152 Benzoxepines |
| 02/11/1997 | US5602144 Thienopyridones |
| 02/11/1997 | US5602138 Neurokinin a antagonists; treating asthma |
| 02/11/1997 | US5602137 Treating cardiovascular or circulatory disorders |
| 02/11/1997 | US5602136 Cardiovascular and nervous system disorders |
| 02/11/1997 | US5602134 Useful for treating animals suffering from congestive heart failure |
| 02/11/1997 | US5602133 Treatment of polycystic ovary syndrome |
| 02/11/1997 | US5602132 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
| 02/11/1997 | US5602122 Method for lowering total serum cholesterol and treating hypercholesterolemia with aminoacetylmercapto derivatives |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5601845 Cores containing diltiazem(or salt) and microcrystalline cellulose coated with ethyl cellulose, for controlled release oral drug delivery |
| 02/11/1997 | US5601839 Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
| 02/11/1997 | US5601804 Antiplaque agent |
| 02/11/1997 | CA2054212C Method for polymerization of epoxide compounds |
| 02/11/1997 | CA2045605C Treatment of leukocyte dysfunction with gm-csf |
| 02/06/1997 | WO1997004092A1 P53 protein variants and therapeutical uses thereof |
| 02/06/1997 | WO1997003973A1 4,5-diaryl oxazole derivatives |
| 02/06/1997 | WO1997003951A1 Esters and amides as pla2 inhibitors |
| 02/06/1997 | WO1997003678A1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 02/06/1997 | WO1997003669A1 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls |
| 02/06/1997 | WO1997003663A1 NON-β-OXIDIZABLE FATTY ACID ANALOGUES, THEIR USES AS THERAPEUTIC ACTIVE MEDICAMENTS, AND PREPARATION THEREOF |
| 02/06/1997 | CA2227466A1 Esters and amides as pla2 inhibitors |
| 02/06/1997 | CA2227442A1 4,5-diaryl oxazole derivatives |
| 02/06/1997 | CA2227034A1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 02/06/1997 | CA2226871A1 Non-.beta.-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof |
| 02/06/1997 | CA2219501A1 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls |
| 02/05/1997 | EP0757039A1 Endothelin receptor antagonists |